Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 10/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3790139 | 0.91 | CHRM3 (0.46) | CHRM3TRPV1BRD9RXFP1HSP90AA1 | |
| SCHEMBL18535719 | 0.90 | BRD9 (0.50) | CHRM3TRPV1BRD9RXFP1HSP90AA1 | |
| SCHEMBL3786623 | 0.90 | CHRM3 (0.46) | CHRM3TRPV1BRD9RXFP1HSP90AA1 | |
| SCHEMBL3781977 | 0.90 | CHRM3 (0.44) | CHRM3TRPV1BRD9RXFP1HSP90AA1 | |
| SCHEMBL3784682 | 0.85 | TRPV1 (0.46) | CHRM3TRPV1BRD9RXFP1HSP90AA1 | |
| SCHEMBL28444082 | 0.84 | CHRM3 (0.52) | CHRM3BRD9MEN1ALDH1A1LMNA | |
| SCHEMBL18539773 | 0.84 | BRD9 (0.48) | CHRM3TRPV1BRD9RXFP1HSP90AA1 | |
| SCHEMBL3783438 | 0.84 | BRD9 (0.46) | CHRM3BRD9RXFP1HSP90AA1HSP90AB1 | |
| SCHEMBL3792310 | 0.83 | BRD4 (0.41) | CHRM3BRD9ALDH1A1BRD4CREBBP | |
| SCHEMBL3792928 | 0.83 | BRD9 (0.46) | CHRM3TRPV1BRD9RXFP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | CHRM3 1707/4885TRPV1 1353/4885BRD9 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.